Research

Hormonal

Elevated plasma levels of endotrophin, the C-terminal cleavage product of collagen type VI alpha 3 (COL6A3), causally increase the risk of coronary artery disease, acting as a primary mediator linking obesity to cardiometabolic disease.

Obesity increases the risk of heart disease partly by raising levels of a specific protein fragment called endotrophin. This fragment is created when body fat increases, specifically from abdominal subcutaneous fat. The good news is that losing body fat reduces these levels. Therefore, weight loss interventions that reduce abdominal adiposity are likely to lower this specific biological risk factor for coronary artery disease.

StrongSupportsVERY_HIGH confidence
Notably, the carboxyl terminus product of COL6A3, endotrophin, drove this effect... COL6A3 levels were strongly increased by body mass index and increased coronary artery disease risk.
Satoshi Yoshiji et al. · Nature Genetics · 2025

Why this rating

The claim is supported by multiple orthogonal lines of evidence including two-step Mendelian randomization, colocalization, observational cohorts (UK Biobank, EPIC-Norfolk), and single-cell RNA sequencing.

Source

Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease

Satoshi Yoshiji et al. · Nature Genetics · 2025

DOI 10.1038/s41588-024-02052-7

cohortCited 25×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →